Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program.
Venner E, Muzny D, Smith JD, Walker K, Neben CL, Lockwood CM, Empey PE, Metcalf GA, Kachulis C; All of Us Research Program Regulatory Working Group; Mian S, Musick A, Rehm HL, Harrison S, Gabriel S, Gibbs RA, Nickerson D, Zhou AY, Doheny K, Ozenberger B, Topper SE, Lennon NJ.
Venner E, et al. Among authors: muzny d.
Genome Med. 2022 Mar 28;14(1):34. doi: 10.1186/s13073-022-01031-z.
Genome Med. 2022.
PMID: 35346344
Free PMC article.